________________________________ Substance Use Disorders and Pain Management: MATE Act Training Substance Use Disorders and Pain Management: MATE Act Training ________________________________ Substance Use Disorders and Pain Management: MATE Act Training MDNJ08SU — 8 CREDIT S R elease D ate : 05/01/23 E xpiration D ate : 04/30/26 In addition to receiving AMA PRA Category 1 Credit TM , physicians participating in Maintenance of Certification will receive the following points appropriate to their certifying board: 8 ABIM MOC Points, 8 ABS MOC Points, 8 ABA MOCA Points, 8 ABP MOC Points, 8 ABPath CC Points.
7. Evaluate behaviors that may indicate drug seeking or diverting as well as approaches for patients suspected of misusing opioids. 8. Identify state and federal laws governing the proper prescription and monitoring of controlled substances. Faculty Mark Rose, BS, MA, LP , is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer- reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations. Faculty Disclosure Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Division Planners John M. Leonard, MD Margo A. Halm, RN, PhD, ACNS-BC Randall L. Allen, PharmD Senior Director of Development and Academic Affairs Sarah Campbell
HOW TO RECEIVE CREDIT
• Read the enclosed course. • Complete the final examination questions at the end. A score of 70% is required. • Return your customer information/answer sheet, evaluation, and payment to InforMed by mail or complete online at BOOK.CME.EDU.
Audience This course is designed for all dental professionals who may alter prescribing practices or intervene to help meet the needs of patients with substance use disorders. Course Objective The purpose of this course is to provide dental professionals who prescribe or distribute controlled substances with an appreciation for the complexities of managing patients with substance use disorders and comorbid pain in order to provide the best possible patient care and to prevent a growing social problem. Learning Outcomes Upon completion of this course, you should be able to: 1. Outline substance use disorder risk factors, screening, and diagnosis. 2. Describe the role of psychosocial therapies in the management of substance use disorders. 3. Compare and contrast available pharma-
cotherapeutic options for the treatment of alcohol, tobacco, and opioid use disorders.
4. Discuss the impact of polysubstance use and co-occurring mental disorders and substance use disorder presentation and treatment. 5. Review legal and ethical issues related to substance use disorder treatment. 6. Create comprehensive treatment plans for patients with pain that address patient needs as well as drug diversion prevention.
39
MDNJ1525
Powered by FlippingBook